|
|
|
| Professor Liu Jianqiu′s clinical experience in treating chronic obstructive pulmonary disease with syndrome of turbid phlegm obstructing lung by Modified Maxing Ersan Decoction |
| WANG Xuehui1 MA Ying2 LI Zhuying1 |
1.Department of Respiration, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
2.the First Clinical Medical College, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China |
|
|
|
Abstract This paper introduces Professor Liu Jianqiu′s experience in treating chronic obstructive pulmonary disease with syndrome of turbid phlegm obstructing lung by Modified Maxing Ersan Decoction. Professor Liu believes that the pathogenesis of chronic obstructive pulmonary disease is the interaction between "vital qi deficiency" and "pathogen excess", both are involved in the development of disease. And for the treatment of this disease, Professor Liu also points out that we should first distinguish deficiency syndrome and reality syndrome of the disease. In most cases, the stable period of chronic obstructive pulmonary disease is usually characterized by deficiency syndrome, while in its acute attack stage, it is characterized by excess syndrome, and the occurrence of its "excess" syndrome is mostly based on the premise of "deficiency", the disease is mainly caused by phlegm turbid touching the deficiency of the original. Therefore, it is necessary to treat the "manifestation" first and then take into account the "root cause", so as to achieve the effect of ventilating lung qi for dissipating phlegm and descending qi to relieve asthma. Modified Maxing Ersan Decoction was made by Professor Liu according to the characteristics and the corresponding symptoms of this disease, combined with the efficacy and compatibility of drugs and years of clinical experience. It has been applied for many years and achieved satisfactory results, which is worthy of further exploration and application in clinic.
|
|
|
|
|
|
[1] 黄伟.苏子降气汤合三子养亲汤治疗慢性阻塞性肺病急性加重期临床观察[J].中国中医药现代远程教育，2019， 17（9）：63-64.
[2] 覃光辉，高鹏飞，陈碧琴，等.六孔灸盒灸法治疗稳定期慢性阻塞性肺疾病的临床研究[J].上海针灸杂志，2017， 36（7）：799-802.
[3] 马嘉蓉，刘永刚，吕华.吕华运用开泄法治疗慢性阻塞性肺疾病急性加重期经验[J].山东中医药大学学报，2017， 41（3）：238-241.
[4] 刘日红.自拟清肺化痰祛瘀汤治疗慢性阻塞性肺疾病急性加重期的临床观察[J].中华中医药学刊，2013，31（6）：1439-1441.
[5] 刘志刚，孙宜芬，孟红旗.苏子降气汤治疗慢性阻塞性肺病急性加重疗效观察[J].临床肺科杂志，2016，21（8）：1442-1445.
[6] 张险峰.痰热清注射液联合胸腺肽治疗慢性阻塞性肺疾病急性加重期患者的疗效研究[J].中国医药科学，2018， 8（11）：55-57.
[7] 黄玲，王艳宁，吴曙粤.中药麻黄药理作用研究进展[J].中外医疗，2018，37（7）：195-198.
[8] 杨昕宇，肖长芳，张凯熠，等.麻黄临床应用与药理作用研究进展[J].中华中医药学刊，2015，33（12）：2874-2877.
[9] 王均秀，吴鹏，张学兰，等.苦杏仁炮制的现代研究进展[J].山东中医杂志，2016，35（9）：840-842.
[10] 王彬辉，章文红，张晓芬，等.苦杏仁苷提取工艺及药理作用研究新进展[J].中华中医药学刊，2014，32（2）：381-384.
[11] 赵振华，李媛，季冬青，等.莱菔子化学成分与药理作用研究进展[J].食品与药品，2017，19（2）：147-151.
[12] 何育佩，郝二伟，谢金玲，等.紫苏药理作用及其化学物质基础研究进展[J].中草药，2018，49（16）：3957-3968.
[13] 马屏南.紫苏子镇咳、祛痰、平喘作用的药理研究[J].中国实用医药，2015，10（10）：159-160.
[14] 刘洋，王四旺，唐志书.白前的现代研究与开发应用前景[J].西北药学杂志，2015，30（6）：768-770.
[15] 张明发，沈雅琴.半夏提取物对呼吸和消化系统药理作用的研究进展[J].抗感染药学，2017，14（8）：1457-1462.
[16] 龚道锋，王甫成，纪东汉，等.中药半夏化学成分及其药理、毒理活性研究进展[J].长江大学学报：自科版，2015， 12（18）：77-79.
[17] 广妍鹭.浅析金银花的药理作用与临床应用[J].中国医药指南，2018，16（35）：164-165.
[18] 赵珮妮，和法涛，宋烨，等.白果的特异生物活性和药理作用研究进展[J].化工进展，2017，36（S1）：366-371.
[19] 唐远鹏，曾靖，黄起壬.白果内酯药理作用的研究[J].赣南医学院学报，2015，35（1）：153-155.
[20] 黄敬文，高宏伟，段剑飞.地龙的化学成分和药理作用研究进展[J].中医药导报，2018，24（12）：104-107.
[21] 范玲，王鑫，朱晓静，等.紫菀化学成分及药理作用研究进展[J].吉林中医药，2019，39（2）：269-273. |
|
|
|
